Oscar Health, Inc. (NYSE:OSCR) Q1 2024 Earnings Call Transcript

Page 2 of 2

John Ransom: And then the PBM, how much did that help?

Scott Blackley: I am sorry, say it again?

Mark Bertolini: PBM.

John Ransom: The PBM re-contract how much does that help year-over-year?

Scott Blackley: Yes. And the PBM, like we’re not going to call out specifically the impact of that, it is embedded in the performance. Obviously, it really ultimately gets into what did you price for? We built that PBM into the pricing and we are seeing margin. And so, clearly PBM is a significant driver of our ability to price at a level that was competitive and continue to drive margin improvement.

John Ransom: Thank you.

Operator: We have reached the end of the Question-And-Answer Session. Thank you for attending today’s conference call. Have a wonderful day. And you may now disconnect.

Follow Oscar Health Inc. (NYSE:OSCR)

Page 2 of 2